Max Raskin

Partner

New York
max.raskin@lw.com
+1.212.906.1781

PRACTICES

  • Executive Compensation, Employment & Benefits
  • Tax

BAR QUALIFICATIONS

  • New York

EDUCATION

  • J.D., The University of Texas School of Law, 2013
  • BA, State University of New York, Buffalo, 2010
    summa cum laude
  • BS, State University of New York, Buffalo, 2010
    summa cum laude

LANGUAGES SPOKEN

  • English

PROFILE

Max Raskin represents clients across the full investment lifecycle of executive compensation, employee benefits, and equity matters that arise in the context of public and private mergers and acquisitions. 

Max leverages trusted client relationships and a keen commercial sensibility to structure, negotiate, and implement incentive compensation plans and arrangements for public and private companies, private equity funds, management teams, and individual executives relating to:

  • Employment, severance, and consulting agreements
  • Changes in control
  • Non-competition, retention, and deferred compensation
  • Cash-based and equity-based compensation
  • Golden parachute excise tax strategy

Before joining Latham, Max worked for a Big Four accounting firm, where he performed E&P modeling, foreign tax credit modeling, and international tax structuring for global M&A transactions.

Max maintains an active pro bono practice and regularly advises CO/LAB Theater Group — a nonprofit organization that offers individuals with developmental disabilities a creative and social outlet through theater arts — on employment, compensation, and labor issues.

EXPERIENCE

Max's recent experience includes representing:

Public Companies

  • Endeavor Group Holdings
  • Farfetch
  • IHS Towers
  • Printful
  • Vivid Seats

Private Companies

  • Milan Laser
  • SRS Distribution
  • West Shore Home

Financial Institutions and Private Equity Firms

  • Cinven
  • Consonance Capital Partners
  • CVC Capital Partners
  • Grey Lion Capital
  • GTCR
  • Leonard Green & Partners
  • Odyssey Investment Partners
  • Palladin Consumer Retail Partners
  • WindRose Health Investors